Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415091810> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2415091810 endingPage "75" @default.
- W2415091810 startingPage "263" @default.
- W2415091810 abstract "Relative to resting liver, Morris hepatomas with different growth rates (3924A, 5123D, 7800, and 7777) all had higher (two to eightfold) levels (activity/gm tissue) of RNA polymerase I. Only the most rapidly growing tumor (hepatoma 3924A) showed a substantial increase (fivefold) in RNA polymerase III activity. RNA polymerase II activity/gm tissue in the hepatomas was similar to that in resting liver. The elevation in the hepatoma RNA polymerase I activity resulted from both an increase in the number of transcriptionally active enzyme molecules and an increase in the specific activity of the enzyme as a result of phosphorylation. Phosphorylation of RNA polymerase I from Morris hepatoma 3924A could be catalyzed either by an endogenous protein kinase or by a highly purified preparation of NII protein kinase from the same tumor. Three out of eight polypeptides (Mr 120,000, 65,000, and 25,000) or RNA polymerase I were phosphorylated. Phosphorylation resulted in enhanced RNA synthesis at the level of chain elongation. Another nuclear protein kinase, NI, had no significant effect on RNA polymerase I. The activity and/or amount of the NII protein kinase was significantly reduced in resting liver, which correlated with decreased specific activity of the liver RNA polymerase I. Anti-RNA polymerase I antibodies were found in the sera of patients with rheumatic autoimmune diseases such as systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), and rheumatoid arthritis (RA). Sera from these patients were capable of specifically inhibiting RNA polymerase I activity in vitro. Antibodies were produced predominantly against three of the polypeptides--S3 (Mr 65,000), S4 (Mr 42,000), and S5 (Mr 25,000) of RNA polymerase I. The spectrum and proportion of the antibodies against these three subunits differ with each patient and with the type of the autoimmune disease. These observations indicate that (1) the NII kinase can regulate RNA polymerase I activity, (2) protein kinase NII is associated with the polymerase I enzyme complex, and (3) certain polypeptides of this enzyme complex may be the target antigens in rheumatic autoimmune disease." @default.
- W2415091810 created "2016-06-24" @default.
- W2415091810 creator A5008085856 @default.
- W2415091810 creator A5011367528 @default.
- W2415091810 creator A5028703055 @default.
- W2415091810 date "1983-01-01" @default.
- W2415091810 modified "2023-09-23" @default.
- W2415091810 title "Regulation of RNA polymerase I by phosphorylation and production of anti-RNA polymerase I antibodies in rheumatic autoimmune diseases." @default.
- W2415091810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6604044" @default.
- W2415091810 hasPublicationYear "1983" @default.
- W2415091810 type Work @default.
- W2415091810 sameAs 2415091810 @default.
- W2415091810 citedByCount "0" @default.
- W2415091810 crossrefType "journal-article" @default.
- W2415091810 hasAuthorship W2415091810A5008085856 @default.
- W2415091810 hasAuthorship W2415091810A5011367528 @default.
- W2415091810 hasAuthorship W2415091810A5028703055 @default.
- W2415091810 hasConcept C100299639 @default.
- W2415091810 hasConcept C101762097 @default.
- W2415091810 hasConcept C104317684 @default.
- W2415091810 hasConcept C11960822 @default.
- W2415091810 hasConcept C150194340 @default.
- W2415091810 hasConcept C153911025 @default.
- W2415091810 hasConcept C181199279 @default.
- W2415091810 hasConcept C25281209 @default.
- W2415091810 hasConcept C2776449523 @default.
- W2415091810 hasConcept C41258723 @default.
- W2415091810 hasConcept C55493867 @default.
- W2415091810 hasConcept C64350747 @default.
- W2415091810 hasConcept C67705224 @default.
- W2415091810 hasConcept C70916841 @default.
- W2415091810 hasConcept C82381507 @default.
- W2415091810 hasConcept C86803240 @default.
- W2415091810 hasConceptScore W2415091810C100299639 @default.
- W2415091810 hasConceptScore W2415091810C101762097 @default.
- W2415091810 hasConceptScore W2415091810C104317684 @default.
- W2415091810 hasConceptScore W2415091810C11960822 @default.
- W2415091810 hasConceptScore W2415091810C150194340 @default.
- W2415091810 hasConceptScore W2415091810C153911025 @default.
- W2415091810 hasConceptScore W2415091810C181199279 @default.
- W2415091810 hasConceptScore W2415091810C25281209 @default.
- W2415091810 hasConceptScore W2415091810C2776449523 @default.
- W2415091810 hasConceptScore W2415091810C41258723 @default.
- W2415091810 hasConceptScore W2415091810C55493867 @default.
- W2415091810 hasConceptScore W2415091810C64350747 @default.
- W2415091810 hasConceptScore W2415091810C67705224 @default.
- W2415091810 hasConceptScore W2415091810C70916841 @default.
- W2415091810 hasConceptScore W2415091810C82381507 @default.
- W2415091810 hasConceptScore W2415091810C86803240 @default.
- W2415091810 hasLocation W24150918101 @default.
- W2415091810 hasOpenAccess W2415091810 @default.
- W2415091810 hasPrimaryLocation W24150918101 @default.
- W2415091810 hasRelatedWork W131787514 @default.
- W2415091810 hasRelatedWork W1557393783 @default.
- W2415091810 hasRelatedWork W1588529304 @default.
- W2415091810 hasRelatedWork W2009968618 @default.
- W2415091810 hasRelatedWork W2029043076 @default.
- W2415091810 hasRelatedWork W2046006082 @default.
- W2415091810 hasRelatedWork W2066465863 @default.
- W2415091810 hasRelatedWork W2092644213 @default.
- W2415091810 hasRelatedWork W2100369513 @default.
- W2415091810 hasRelatedWork W2116015868 @default.
- W2415091810 hasVolume "7" @default.
- W2415091810 isParatext "false" @default.
- W2415091810 isRetracted "false" @default.
- W2415091810 magId "2415091810" @default.
- W2415091810 workType "article" @default.